Print Page     Close Window     

SEC Filings

6-K
AC IMMUNE SA filed this Form 6-K on 08/09/2017
Entire Document
 
 

 

Balance Sheets

 

   Notes  As of
June 30,
2017
  As of
December 31,
2016
in CHF thousands      
ASSETS         
          
Non-current assets               
Property, plant and equipment    5    2,403    1,120 
Financial assets         126    86 
Total non-current assets         2,529    1,206 
                
Current assets               
Prepaid expenses    6    1,964    1,278 
Accrued income         1,079    889 
Finance receivable    7    146    - 
Other current receivables         1,390    517 
Cash and cash equivalents         124,180    152,210 
Total current assets         128,759    154,894 
Total assets         131,288    156,100 
                
SHAREHOLDERS’ EQUITY AND LIABILITIES               
                
Shareholders’ equity               
Share capital         1,142    1,135 
Share premium         188,207    188,166 
Accumulated losses         (68,457)   (46,921)
Total shareholders’ equity         120,892    142,380 
                
Non-current liabilities               
Accrued interest – long-term    7    72    - 
Long-term financing obligation    7    386    - 
Net employee defined benefit liabilities         3,976    3,798 
Total non-current liabilities         4,434    3,798 
                
Current liabilities               
Trade payables and other payables         954    4,035 
Accrued expenses         4,667    5,366 
Deferred income         341    521 
Total current liabilities         5,962    9,922 
Total liabilities         10,396    13,720 
Total shareholders’ equity and liabilities         131,288    156,100 

 

The accompanying notes form an integral part of these Interim Condensed Financial Statements (Unaudited).

 

 2


© AC Immune 2015